Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Insight Molecular Diagnostics Inc.
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
August 10, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1×1 Conference
August 4, 2026
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
July 23, 2026
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
July 16, 2026
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
June 29, 2026
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
June 22, 2026
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
May 14, 2026
iMDx to Release First Quarter 2026 Results on May 13, 2026
May 6, 2026
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
April 14, 2026
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
March 20, 2026
1
2
Next Page
→